Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincristine pharmacokinetics during concomitant azole therapy in pediatric acute lymphoblastic leukemia
NL-OMON35826Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vincristine, itraconazole, voriconazole and fluconazole in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Vincristine pharmacokinetics. Started Feb 2012; status: active, not recruiting.
02
Drugs
vincristineitraconazolevoriconazolefluconazole
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON35826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35826.